Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Novel genes involved in pathophysiology of gonadotropin-dependent adrenal tumors in mice.

Doroszko M, Chrusciel M, Belling K, Vuorenoja S, Dalgaard M, Leffers H, Nielsen HB, Huhtaniemi I, Toppari J, Rahman NA.

Mol Cell Endocrinol. 2017 Mar 15;444:9-18. doi: 10.1016/j.mce.2017.01.036. Epub 2017 Jan 25.

2.

Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Chrusciel M, Vuorenoja S, Mohanty B, Rivero-Müller A, Li X, Toppari J, Huhtaniemi I, Rahman NA.

J Cell Sci. 2013 Apr 15;126(Pt 8):1845-57. doi: 10.1242/jcs.119347. Epub 2013 Feb 26.

3.

Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter.

Vuorenoja S, Mohanty BP, Arola J, Huhtaniemi I, Toppari J, Rahman NA.

Endocr Relat Cancer. 2009 Jun;16(2):549-64. doi: 10.1677/ERC-08-0232. Epub 2009 Mar 4.

4.

Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.

Vuorenoja S, Rivero-Müller A, Ziecik AJ, Huhtaniemi I, Toppari J, Rahman NA.

Endocr Relat Cancer. 2008 Jun;15(2):635-48. doi: 10.1677/ERC-08-0015.

5.

Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.

Rivero-Müller A, Vuorenoja S, Tuominen M, Wacławik A, Brokken LJ, Ziecik AJ, Huhtaniemi I, Rahman NA.

Mol Cell Endocrinol. 2007 Apr 15;269(1-2):17-25. Epub 2007 Feb 12. Review.

PMID:
17363137
6.

Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.

Vuorenoja S, Rivero-Muller A, Kiiveri S, Bielinska M, Heikinheimo M, Wilson DB, Huhtaniemi IT, Rahman NA.

Mol Cell Endocrinol. 2007 Apr 15;269(1-2):38-45. Epub 2007 Feb 6. Review.

PMID:
17337116

Supplemental Content

Loading ...
Support Center